[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":6182741.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":34487660.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-5547723.0,"OtherIncome_2_Q2_USD":602.0,"OtherIncome_1_Q2_USD":602.0,"OperatingIncomeLoss_2_Q2_USD":-3588802.0,"OperatingIncomeLoss_1_Q2_USD":-1538681.0,"OperatingCostsAndExpenses_2_Q2_USD":3588802.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":51313.0,"OperatingCostsAndExpenses_1_Q2_USD":1538681.0,"NetIncomeLoss_2_Q2_USD":30898858.0,"NetIncomeLoss_1_Q2_USD":-7130104.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-828940.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-594815.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1109270.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":null,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":null,"NotesPayableRelatedPartiesClassifiedCurrent_0_Q2_USD":1109270.0,"PaymentsToAcquireInvestments_2_Q2_USD":714865.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure_0_Q2_USD":1846785.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":128365499.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":-47404604.0,"StockholdersEquity_0_Q2_USD":-47404604.0,"SharePrice_0_Q2_USD":10.18,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0088,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.19,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0_Q2_USD":11.5,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-47405323.0,"ProfitLoss_1_Q2_USD":-7130104.0,"ProceedsFromSaleOfTrustAssetsToPayExpenses_2_Q2_USD":120050.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":1109270.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":1500000.0,"PrepaidTaxes_0_Q2_USD":6287.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PreferredStockSharesIssued_0_Q2_shares":null,"MarketableSecuritiesGainLoss_2_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":35247365.0,"MarketableSecuritiesGainLoss_1_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":128415406.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":29350000.0,"DeferredOfferingCosts_0_Q2_USD":16473117.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":null,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-602.0,"CommonStockValue_0_Q2_USD":null,"CommonStockConvertibleConversionPriceIncrease_2_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":1.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":211.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":128357595.0,"AssetsHeldInTrust_0_Q2_USD":128357595.0,"AssetsCurrent_0_Q2_USD":57811.0,"Assets_0_Q2_USD":128415406.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":21375000.0,"AdditionalPaidInCapital_0_Q2_USD":null,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-314485.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_2_Q2_USD":5000000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":5557500.0,"Liabilities_0_Q2_USD":47454511.0,"InvestmentIncomeInterest_2_Q2_USD":37058.0,"InvestmentIncomeInterest_1_Q2_USD":9175.0,"InterestIncomeOther_2_Q2_USD":37058.0,"InterestIncomeOther_1_Q2_USD":9175.0,"IncreaseDecreaseInPrepaidTaxes_2_Q2_USD":-4094.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":17101.0,"IncreaseDecreaseInDerivativeLiabilities_2_Q2_USD":-34450000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":null,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":2772869.0,"IncomeTaxExpenseBenefit_2_Q2_USD":null,"IncomeTaxExpenseBenefit_1_Q2_USD":43700.0,"IncomeTaxesPaid_2_Q2_USD":null,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":30898858.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-7086404.0,"FederalDepositInsuranceCorporationPremiumExpense_2_Q2_USD":250000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-34450000.0,"LiabilitiesCurrent_0_Q2_USD":7292011.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":20502385.0,"Ticker":"CELU","CIK":"1752828","name":"CELULARITY INC","OfficialName":"Celularity Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1622347796.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210819"}]